Current evidence on VEGF+405G/C polymorphism and malignancy susceptibility: A meta-analysis involving 30 studies

Twin Research and Human Genetics

Volumn 15, Issue 4, 2012, Pages 496-502

  Hu, Kai ^a   Zhang, Yong ^a   Wang, Rensheng ^a   Li, Guojian ^a   Li, Guihua ^a   Zhang, Dawei ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

malignancy; single nucleotide polymorphism; susceptibility; vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A;

AFRICAN AMERICAN; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; PUBLISHING; SENSITIVITY ANALYSIS; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM;

AFRICAN AMERICANS; ALLELES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866454567     PISSN: 18324274     EISSN: None     Source Type: Journal    
DOI: 10.1017/thg.2012.34     Document Type: Article

References (43)

1. Al-Moundhri, M. S., Al-Nabhani, M., Burney, I. A., Al-Farsi, A., & Al-Bahrani, B. (2009). Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms - A casecontrol study in an Omani population. Molecular Carcinogenesis, 48, 1170-1176.
2. Amano, M., Yoshida, S., Kennedy, S., Takemura, N., Deguchi, M., Ohara, N., & Maruo, T. (2008). Association study of vascular endothelial growth factor gene polymorphisms in endometrial carcinomas ina Japanese population. European Journal of Gynaecological Oncology, 29, 333-337.
3. Awata, T., Inoue, K., Kurihara, S., Ohkubo, T., Watanabe, M., Inukai, K., Inoue, I., & Katayama, S. (2002). A common polymorphism in the 5-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes, 51, 1635-1639.
4. Balasubramanian, S. P., Cox, A., Cross, S. S., Higham, S. E., Brown, N. J., & Reed, M. W. (2007). Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. International Journal of Cancer, 121, 1009-1016.
5. Brogan, I. J., Khan, N., Isaac, K., Hutchinson, J. A., Pravica, V., & Hutchinson, I. V. (1999). Novel polymorphisms in the promoter and 5-UTR regions of the human vascular endothelial growth factor gene. Human Immunology, 60, 1245-1249.
6. Bruyere, F., Hovens, C. M., Marson, M., Arcier, B. F. D., Costello, A. J., Waiter, H., Linassier, C., & Ohresser, M. (2010). VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma. Journal of Urology, 184, 1273-1278.
7. Chae, Y. S.,Kim, J.G., Sohn, S.K., Cho, Y. Y.,Moon, J. H.,Bae, H. I., Park, J. K., Lee,M. H., Chung, H. Y., & Yu,W. (2006). Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology, 71, 266-272.
8. Chae, Y. S., Kim, J. G., Sohn, S. K., Cho, Y. Y., Ahn, B. M., Moon, J. H., Jeon, S. W., Park, J. Y., Lee, I. T., Choi, G. S., & Jun, S. H. (2008). Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. Journal of Korean Medical Science, 23, 421-427.
9. Dass, C. R.,&Su,T. (2000).Delivery of lipoplexes for genotherapy of solid tumours: Role of vascular endothelial cells. Journal of Pharmacy and Pharmacology, 52, 1301-1317.
10. Dassoulas, K., Gazouli, M., Rizos, S., Theodoropoulos, G., Christoni, Z., Nikiteas, N., & Karakitsos, P. (2009). Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Molecular Carcinogenesis, 48, 563-569.
11. Ferrara, N., & Henzel, W. J. (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochemical and Biophysical Research Communications, 161, 851-858.
12. Folkman, J. (1971). Tumor angiogenesis: Therapeutic implications. New England Journal of Medicine, 285, 1182-1186.
13. Galimberti, S., Nagy, B., Palumbo, G. A., Ciancia, E., Buda, G., Orciuolo, E., Melosi, A., Lambelet, P., Ronca, F., & Petrini, M. (2010). Vascular endothelial growth factor polymorphisms in mantle cell lymphoma. Acta Haematologica, 123, 91-95.
14. Garcia-Closas, M., Malats, N., Real, F. X., Yeager, M., Welch, R., Silverman, D., Kogevinas, M., Dosemeci, M., Figueroa, J., Chatterjee, N., Tard́ on, A., Serra, C., Carrato, A., Garćia-Closas, R., Murta-Nascimento, C., Rothman, N., & Chanock, S. J. (2007). Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genetics, 3, 287-293.
15. Guan, X., Zhao, H., Niu, J., Tang, D., Ajani, J. A., & Wei, Q. (2009). The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer. BMC Gastroenterology, 9, 77.
16. Hofmann, G., Langsenlehner, U., Renner, W., Langsenlehner, T., Yazdani-Biuki, B., Clar, H., Gerger, A., Wehrschuetz, M., Samonigg, H., & Krippl, P. (2008). Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. Journal of Cancer Research and Clinical Oncology, 134, 591-595.
17. Howell, W., Bateman, A., Turner, S., Collins, A., & Theaker, J. (2002). Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes and Immunity, 3, 229-232.
18. Hsiao, P., Lu, M.,Chiang, F., Shin, S.,Tai,Y.,&Juo, S.H (2007). Vascular endothelial growth factor gene polymorphisms in thyroid cancer. Journal of Endocrinology, 195, 265-270.
19. Jacobs, E. J., Feigelson, H. S., Bain, E. B., Brady, K. A., Rodriguez, C., Stevens, V. L., Patel, A. V., Thun, M. J., & Calle, E. E. (2006). Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Research, 8, R22.
20. Jin, Q., Hemminki, K., Enquist, K., Lenner, P., Grzybowska, E., Klaes, R., Henriksson, R., Chen, B., Pamula, J., Pekala, W., Zientek, H., Rogozinska-Szczepka, J., Utracka-Hutka, B., Hallmans, G., & F?orsti, A. (2005). Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clinical Cancer Research, 11, 3647-3653.
21. Kammerer, P.W., Toyoshima, T., Eletr, S., Kammerer, P., Kuhr, K., AI-Nawas, B., & Brieger, J. (2010). Single nucleotide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinoma. Journal of Oral Pathology andMedicine, 39, 786-792.
22. Kataoka, N., Cai, Q., Wen, W., Shu, X., Jin, F., Gao, Y. T., & Zheng, W. (2006). Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiology, Biomarkers and Prevention, 15, 1148-1152.
23. Ke, Q., Liang, J., Wang, L. N., Hu, Z. B., Jin, G. F., Zhou, Y., Wang, J.M.,Tan,Y.F., Hua,Z.L., Xu,Y.C., Shen, J., & Shen, H. B. (2008). Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer. Molecular Carcinogenesis, 47, 647-651.
24. Kim, Y. H., Kim, M. A., Park, I., Park, W., Kim, J. W., Kim, S. C., Park, N. H., Song, Y. S., & Kang, S. B. (2010). VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival. Gynecological Oncology, 119, 232-236.
25. Koukourakis, M. I., Papazoglou, D., Giatromanolaki, A., Bougioukas, G., Maltezos, E., & Sivridis, E. (2004). VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer,46, 293-298.
26. Langsenlehner, T., Langsenlehner, U., Renner, W., Krippl, P., Mayer, R., Wascher, T. C., & Kapp, K. S. (2008). Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer. European Journal of Cancer, 44, 1572-1576.
27. Lee, S. J., Lee, S. Y., Jeon, H., Park, S. H., Jang, J. S., Lee, G. Y., Son, J. W., Kim, C. H., Lee, W. K., Kam, S., Park, R. W., Park, T. I., Kang, Y. M., Kim, I. S., Jung, T. H., & Park, J. Y. (2005). Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiology, Biomarkers and Prevention, 14, 571-575.
28. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., & Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309.
29. Li, R., Zhao, Y., Fan,W., Chen, H., Chen, Y., Liu, Y., Chen, G., Zhou, K.,Huang, F.,Mao, Y., Zhou, L., Lu, D., & Shugart, Y. Y. (2011). Possible association between polymorphisms of human vascular endothelial growth factor A gene and susceptibility to glioma in a Chinese population. International Journal of Cancer, 128, 166-175.
30. Maltese, P., Canestrari, E., Ruzzo, A., Graziano, F., Falcone, A., Loupakis, F., Tonini, G., Santini, D., &Magnani, M (2009). VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. International Journal of Colorectal Disease, 24, 165-170.
31. Murohara, T., Horowitz, J. R., Silver, M., Tsurumi, Y., Chen, D., Sullivan, A., & Isner, J. M. (1998). Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation, 97, 99-107.
32. Oliveira, C., Lourenço, G. J., Silva, P. M. R., Cardoso-Filho, C., Favarelli,M. H., Gonçales, N. S.,Gurgel, M. S., & Lima, C. S. (2011). Polymorphisms in the 5- and3- -untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics. Tumour Biology, 32, 295-300.
33. Salajegheh, A., Smith, R. A., Kasem, K., Gopalan, V., Nassiri, M. R., William, R., & Lam, A. K. (2010). Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: Potential markers for aggressive phenotypes. European Journal of Surgical Oncology, 37, 93-99.
34. Sfar, S., Hassen, E., Saad, H., Mosbah, F., & Chouchane, L. (2006). Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine, 35, 21-28.
35. Steffensen, K. D.,Waldstrøm,M., Brandslund, I., & Jakobsen, A. (2010). The relationship of VEGF polymorphisms with serumVEGF levels and progression-free survival in patients with epithelial ovarian cancer. Gynecological Oncology, 117, 109-116.
36. Tzanakis, N., Gazouli, M., Rallis, G., Giannopoulos, G., Papaconstantinou, I., Theodoropoulos, G., Pikoulis, E., Tsigris, C., Karakitsos, P., Peros, G., & Nikiteas, N. (2006). Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. Journal of Surgical Oncology, 94, 624-630.
37. Vincenti, V., Cassano, C., Rocchi, M., & Persico, G. (1996). Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation, 93, 1493-1495.
38. Watson, C. J., Webb, N. J., Bottomley, M. J., & Brenchley, P. E. (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production. Cytokine, 12, 1232-1235.
39. Wolf, G., Aigner, R. M., Schaffler, G., Langsenlehner, U., Renner, W., Samonigg, H., Yazdani-Biuki, B., & Krippl, P. (2004). The 936C/T polymorphism of the gene for vascular endothelial growth factor is associated with 18Ffluorodeoxyglucose uptake. Breast Cancer Research and Treatment, 88, 205-208.
40. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature, 407, 242-248.
41. Zhai, R., Liu, G., Asomaning, K., Su, L., Kulke, M. H., Heist, R. S., Nishioka, N. S., Lynch, T. J., Wain, J. C., Lin, X., & Christiani, D. C. (2008a). Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis, 29, 2330-2334.
42. Zhai,R., Liu,G.,Zhou,W., Su,L.,Heist,R. S.,Lynch,T. J.,Wain, J. C., Asomaning, K., Lin, X., & Christiani, D. C. (2008b). Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Clinical Cancer Research, 14, 612-617.
43. Zhou, Y., Li, N., Zhuang, W., & Wu, X. (2011). Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population. Molecular Carcinogenesis, 50, 184-188.